WO2003068921A3 - Therapeutic polypeptides, nucleic acids encoding same, and methods of use - Google Patents
Therapeutic polypeptides, nucleic acids encoding same, and methods of use Download PDFInfo
- Publication number
- WO2003068921A3 WO2003068921A3 PCT/US2003/004188 US0304188W WO03068921A3 WO 2003068921 A3 WO2003068921 A3 WO 2003068921A3 US 0304188 W US0304188 W US 0304188W WO 03068921 A3 WO03068921 A3 WO 03068921A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- methods
- nucleic acids
- acids encoding
- encoding same
- therapeutic polypeptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Genetics & Genomics (AREA)
- Hematology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003219743A AU2003219743A1 (en) | 2002-02-12 | 2003-02-12 | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35637502P | 2002-02-12 | 2002-02-12 | |
US60/356,375 | 2002-02-12 | ||
US38708202P | 2002-06-07 | 2002-06-07 | |
US60/387,082 | 2002-06-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2003068921A2 WO2003068921A2 (en) | 2003-08-21 |
WO2003068921A3 true WO2003068921A3 (en) | 2004-04-08 |
Family
ID=27737531
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/004188 WO2003068921A2 (en) | 2002-02-12 | 2003-02-12 | Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003219743A1 (en) |
WO (1) | WO2003068921A2 (en) |
-
2003
- 2003-02-12 WO PCT/US2003/004188 patent/WO2003068921A2/en not_active Application Discontinuation
- 2003-02-12 AU AU2003219743A patent/AU2003219743A1/en not_active Abandoned
Non-Patent Citations (1)
Title |
---|
HUGUET E.L. ET AL.: "Differential expression of human Wnt genes 2, 3, 4 and 7B in human breast cell lines and normal and disease states of human breast tissue", CANCER RES., vol. 54, no. 10, 15 May 1994 (1994-05-15), pages 2615 - 2621, XP002121611 * |
Also Published As
Publication number | Publication date |
---|---|
AU2003219743A1 (en) | 2003-09-04 |
WO2003068921A2 (en) | 2003-08-21 |
AU2003219743A8 (en) | 2003-09-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2003031572A3 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
WO2005078097A3 (en) | RNA INTERFERENCE MEDIATED INHIBITION OF GENE EXPRESSION USING MULTIFUNCTIONAL SHORT INTERFERING NUCLEIC ACID (Multifunctional siNA) | |
HUP0500054A2 (en) | Method for identification of tumor targeting enzymes | |
WO1997045541A3 (en) | Patched genes and their uses | |
WO2001038503A3 (en) | Novel human protein kinases and protein kinase-like enzymes | |
WO1995025171A3 (en) | Dna sequences for matrix metalloproteases, their production and use | |
WO2003076578A3 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
WO2003029429A3 (en) | Traversal of nucleic acid molecules through a fluid space and expression in repair cells | |
WO2001071357A3 (en) | Diagnosis and treatment of breast cancer | |
WO2004018633A3 (en) | Abca13 nucleic acids and proteins, and uses thereof | |
HRP20020093A2 (en) | Polymorphisms in the human mdr-1 gene and their use in diagnostic and therapeutic applications | |
WO2000008157A3 (en) | Human anion transporter genes atnov | |
WO2003068921A3 (en) | Therapeutic polypeptides, nucleic acids encoding same, and methods of use | |
WO2004053075A3 (en) | Compositions, splice variants and methods relating to breast specific genes and proteins | |
WO2005110460A3 (en) | Diagnosis and treatment methods related to aging, especially in muscle (14.1) | |
CY1110911T1 (en) | Human TSC403 gene | |
WO2004013311A3 (en) | Compositions and methods relating to ovarian specific genes and proteins | |
WO2001049879A3 (en) | Methods for comparing gene expression levels or patterns in normal or tumor cells | |
EP1494031A3 (en) | Novel human genes and gene expression products | |
WO2000058464A3 (en) | Rab genes and their uses | |
WO2005014804A3 (en) | Ubiquitin-specific protease | |
WO2004020582A3 (en) | Mammalian genes involved in rapamycin resistance and tumorgenesis: rapr6 genes | |
WO2005023979A3 (en) | Isolated s. mansoni nucleic acid molecules and uses thereof | |
WO2003059148A3 (en) | Gene expression profiles in stomach cancer | |
WO2003066877A3 (en) | Compositions and methods relating to hepatic specific genes and proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |